K
K. Kuan
Researcher at University of Adelaide
Publications - 24
Citations - 531
K. Kuan is an academic researcher from University of Adelaide. The author has contributed to research in topics: ZBLAN & Diamond. The author has an hindex of 9, co-authored 21 publications receiving 467 citations.
Papers
More filters
Journal ArticleDOI
Fifty percent internal slope efficiency femtosecond direct-written Tm 3+:ZBLAN waveguide laser
David G. Lancaster,Simon Gross,Heike Ebendorff-Heidepriem,K. Kuan,Tanya M. Monro,Martin Ams,Alexander Fuerbach,Michael J. Withford +7 more
TL;DR: A 790 nm pumped, Tm³⁺ doped ZBLAN glass buried waveguide laser that produces 47 mW at 1880 nm, with a 50% internal slope efficiency and an M² of 1.7 is reported, which is the most efficient laser created in a glass host via femtosecond waveguide writing.
Journal ArticleDOI
Diamond in Tellurite Glass: a New Medium for Quantum Information
Matthew R. Henderson,Brant C. Gibson,Heike Ebendorff-Heidepriem,K. Kuan,J. O. Orwa,Igor Aharonovich,Snjezana Tomljenovic-Hanic,Andrew D. Greentree,Steven Prawer,Tanya M. Monro +9 more
TL;DR: M. R. Henderson, B. C. Gibson, H. Ebendorff-Heidepriem, K. Kuan, S. Orwa, I. Tomljenovic-Hanic, A. Aharonovich, and T. Prawer.
Journal ArticleDOI
Extruded tellurite glass and fibers with low OH content for mid-infrared applications
TL;DR: Heike Ebendorff-Heidepriem, Kevin Kuan, Michael R. Oermann, Kenton Knight, and Tanya M. Monro as discussed by the authors.
Journal ArticleDOI
New cholesterol esterase inhibitors based on rhodanine and thiazolidinedione scaffolds.
Sabrina Heng,William Tieu,Stephanie Hautmann,K. Kuan,Daniel Sejer Pedersen,Markus Pietsch,Markus Pietsch,Michael Gütschow,Andrew D. Abell +8 more
TL;DR: A new class of inhibitors of pancreatic cholesterol esterase (CEase) based on 'priviledged' 5-benzylidenerhodanine and 4-thiazolidinedione structural scaffolds is presented and molecular docking and detailed kinetic analysis on the amino acid analogs are reported to further understand the associated structure-activity relationships.
Journal ArticleDOI
5-benzylidenerhodanine and 5-benzylidene-2-4-thiazolidinedione based antibacterials.
Ondrej Zvarec,Steven W. Polyak,William Tieu,K. Kuan,Huanqin Dai,Daniel Sejer Pedersen,Renato Morona,Lixin Zhang,Grant W. Booker,Andrew D. Abell +9 more
TL;DR: Improved activity against the clinically more significant Staphylococci with selectivity over Bacillus subtilis ATCC 6633 induced by introduction of a bulky aryl substituent at the 5-position of the core scaffolds.